Repositorio Dspace

Listar por autor "Gironella, Mercedes"

Listar por autor "Gironella, Mercedes"

Ordenar por:Orden:Resultados:

  • High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience 
    González-Calle, Verónica; Rodríguez-Otero, Paula; Calasanz, María-José; Guijarro, Manuela; Martínez-López, Joaquín; Rosiñol, Laura; Hernández-García, Miguel-Teodoro; Teruel, Ana-Isabel; Gironella, Mercedes; Oriol, Albert; de-la-Rubia, Javier; González-Rodríguez, Ana-P; Bargay, Joan; de-Arriba-de-la-Fuente, Felipe; Palomera, Luis; González-Pérez, Marta-Sonia; Sureda, Anna; Ocio, Enrique-M; Lahuerta, Juan-José; Blade, Joan; San-Miguel, Jesús-F; Mateos, María-Victoria; Gutiérrez, Norma-C (Wiley, 2024-12)
    This study examines the impact of cytogenetic abnormalities and their co-segregation on the prognosis of newly diagnosed multiple myeloma patients. The analysis included 1304 patients from four different GEM-PETHEMA clinical ...
  • Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis 
    Cuenca, Isabel; Alameda, Daniel; Sánchez-Vega, Beatriz; Gómez-Sánchez, David; Alignani, Diego; Lasa, Marta; Onecha, Esther; Lecumberri, Ramón; Prosper, Felipe; Ocio, Enrique-M; González, María-Esther; de-Coca, Alfonso; de-la-Rubia, Javier; Gironella, Mercedes; Palomera, Luis; Oriol, Albert; Casanova, María-José; Cabanas, Valentín; Taboada, Francisco; Pérez-Montana, Albert; de-Arriba-de-la-Fuente, Felipe; Puig, Noemi; Carreño-Tarragona, Gonzalo; Barrio, Santiago; de-la-Puerta, José; Ramírez-Payer, Ángel; Krsnik, Isabel; Bargay, Juan-José; Lahuerta, Juan-José; Mateos, María-Victoria; San-Miguel, Jesús-F; Paiva, Bruno; Martínez-López, Joaquín (SPRINGERNATURE, 2021-01)
  • Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance 
    Botta, Cirino; Pérez, Cristina; Larrayoz, Marta; Puig, Noemi; Cedena, María-Teresa; Termini, Rosalinda; Goicoechea, Ibai; Rodríguez, Sara; Zabaleta, Aintzane; López, Aitziber; Sarvide, Sarai; Blanco, Laura; Papetti, Daniele-M; Nobile, Marco-S; Besozzi, Daniela; Gentile, Massimo; Correale, Pierpaolo; Siragusa, Sergio; Oriol, Albert; González-García, María-Esther; Sureda, Anna; de-Arriba-de-la-Fuente, Felipe; Ríos-Tamayo, Rafael; Moraleda-Jiménez, José-María; Gironella, Mercedes; Hernández-García, Miguel-Teodoro; Bargay, Joan; Palomera, Luis; Pérez-Montana, Albert; Goldschmidt, Hartmut; Avet-Loiseau, Herve; Roccaro, Aldo; Orfao, Alberto; Martínez-López, Joaquín; Rosiñol, Laura; Lahuerta, Juan-José; Blade, Joan; Mateos, María-Victoria; San-Miguel, Jesús-F; Martínez-Climent, José-Ángel; Paiva, Bruno (NATURE PORTFOLIO, 2023-09)
    Tumor recognition by T cells is essential for antitumor immunity. A comprehensive characterization of T cell diversity may be key to understanding the success of immunomodulatory drugs and failure of PD-1 blockade in tumors ...
  • Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial 
    Puig, Noemi; Hernández-García, Miguel-Teodoro; Rosiñol, Laura; González, Esther; de-Arriba-de-la-Fuente, Felipe; Oriol, Albert; González-Calle, Verónica; Escalante, Fernando; de-la-Rubia, Javier; Gironella, Mercedes; Ríos, Rafael; García-Sánchez, Ricarda; Arguiáano, José-M; Alegre, Adrián; Martín, Jesús; Gutiérrez, NormaC; Calasanz, María-José; Martín, María-L; Couto, María-del-Carmen; Casanova, María-José; Arnao, Mario; Pérez-Persona, Ernesto; Garzon, Sebastián; González, Marta-S; Martín-Sánchez, Guillermo; Ocio, Enrique-M; Coleman, Morton; Encinas, Cristina; Vale, Ana-M; Teruel, Ana-Isabel; Cortes-Rodríguez, María; Paiva, Bruno; Cedena, María-Teresa; San-Miguel, Jesús-F; Lahuerta, Juan-José; Blade, Joan; Niesvizky, Rubén; Mateos, María-Victoria (SPRINGERNATURE, 2021-05)
    Although case-control analyses have suggested an additive value with the association of clarithromycin to continuous lenalidomide and dexamethasone (Rd), there are not phase III trials confirming these results. In this ...
  • Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma 
    Tamariz-Amador, Luis-Esteban; Rodríguez-Otero, Paula; Jiménez-Ubieto, Ana; Rosinol, Laura; Oriol, Albert; Rios, Rafael; Sureda, Anna; Jesus-Blanchard, María; Teodoro-Hernández, Miguel; Cabanas-Perianes, Valentin; Jarque, Isidro; Bargay, Juan; Gironella, Mercedes; De-Arriba, Felipe; Palomera, Luis; González-Montes, Yolanda; Marti, Josep-M; Krsnik, Isabel; María-Arguinano, José; Esther-González, María; Felipe-Casado, Luis; Pilar-González-Rodríguez, Ana; López-Anglada, Lucia; Puig, Noemi; Teresa-Cedena, María; Paiva, Bruno; Mateos, María-Victoria; San-Miguel, Jesus; Lahuerta, Juan-José; Blade, Joan; Troconiz, Inaki-F (CIG MEDIA GROUP, LP, 2022-09)
    INTRODUCTION: Response kinetics is a well-established prognostic marker in acute lymphoblastic leukemia. The situation is not clear in multiple myeloma (MM) despite having a biomarker for response monitoring (monoclonal ...